References
- AdelmanDTLiebertKJNachtigallLBLamersonMBakkerBAcromegaly: the disease, its impact on patients, and managing the burden of long-term treatmentInt J Gen Med20136313823359786
- BanerjeeAPatelKWrenAMAcromegaly- clinical manifestations and diagnosisPharm J200313273278
- NachtigallLDelgadoASwearingenBLeeHZeriklyRKlibanskiAExtensive clinical experience: changing patterns in diagnosis and therapy of acromegaly over two decadesJ Clin Endocrinol Metab2008932035204118381584
- SchneiderHJSieversCSallerBWittchenHUStallaGKHigh prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levelsClin Endocrinol2008693432435
- CorderoRABarkanALCurrent diagnosis of acromegalyRev Endocr Metab Disord200891131918236162
- CannavòSFerraùFRagoneseMIncreased prevalence of acromegaly in a highly polluted areaEur J Endocrinol2010163450951320621957
- MelmedSMedical progress: AcromegalyN Engl J Med2006355242558257317167139
- AbreuATovarAPCastellanosRChallenges in the diagnosis and management of acromegaly: a focus on comorbiditiesPituitary201619444845727279011
- BrabantGInsulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatmentEur J Endocrinol2003148Suppl 2S15S2012670296
- IsidroMLIglesias DíazPMatías-GuiuXCordidoFAcromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytomaJ Endocrinol Invest200528216216515887863
- ReidTJPostKDBruceJNNabi KanibirMReyes-VidalCMFredaPUFeatures at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosedClin Endocrinol2010722203208
- LugoGPenaLCordidoFClinical manifestations and diagnosis of acromegalyInt J Endocrinol2012201254039822518126
- Ribeiro-OliveiraABarkanAThe changing face of acromegaly--advances in diagnosis and treatmentNat Rev Endocrinol201281060561122733271
- HoldawayIMRajasooryaRCGambleGDFactors influencing mortality in acromegalyJ Clin Endocrinol Metab200489266767414764779
- Ben-ShlomoASheppardMCStephensJMPulgarSMelmedSClinical, quality of life, and economic value of acromegaly disease controlPituitary201114328429421597975
- Kreitschmann-AndermahrISiegelSKleistBDiagnosis and management of acromegaly: the patient’s perspectivePituitary201619326827626742496
- MelarvieSJeevanandamMHoladayNJPetersenSRPulsatile nature of growth hormone levels in critically ill trauma victimsSurgery199511744024087716722
- ClemmonsDRConsensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assaysClin Chem201157455555921285256
- MelmedSAcromegaly pathogenesis and treatmentJ Clin Invest2009119113189320219884662
- CostaACRossiAMartinelliCEMachadoHRMoreiraACAssessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?J Clin Endocrinol Metab20028773142314712107214
- GiustinaAChansonPBronsteinMDA consensus on criteria for cure of acromegalyJ Clin Endocrinol Metab20109573141314820410227
- HamurcuZCakirIDonmez-AltuntasHMicronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegalyMetabolism2011601620162621550080
- BayramFBitgenNDonmez-AltuntasHIncreased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegalyGrowth Horm IGF Res2014241293424382376
- DuttaPHajelaAPathakAClinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: Impact of a multi-disciplinary teamNeurol India201563336036826053808
- DayPFLotoMGGlereanMPicassoMFLovazzanoSGiuntaDHIncidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, ArgentinaArch Endocrinol Metab201660655456127982201
- RosarioPWCalsolariMRLaboratory investigation of acromegaly: Is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result?Arch Endocrinol Metab2015591545825926115
- CordidoFGarcía ArnésJAMarazuela AspirozMTorres VelaEPractical guidelines for diagnosis and treatment of acromegalyEndocrinología y Nutrición2013608457.e145723660006
- PrencipeNFlorianiIGuaraldiFACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed diseaseClin Endocrinol2016843380385
- ÖbergKLambertsSWSomatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and futureEndocr Relat Cancer20162312R551R56627697899
- BuchfelderMSchlafferSSurgical treatment of pituitary tumours. Best practice & researchClin Endocrinol Metab200923677692
- CottierJPDestrieuxCBrunereauLCavernous sinus invasion by pituitary adenoma: MR imagingRadiology2000215246346910796926
- TiroshAShimonIComplications of acromegaly: thyroid and colonPituitary2017201707527631334
- ChiaghanaCOBauerfeindJMSulekCAGoldsteinJCAwoniyiCAAcromegaly discovered during a routine out-patient surgical procedure: a case reportJ Med Case Rep201711116928645320